13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q4 2018. See the latest, Q3 2026 →

Reported value

$1.73B

−18% on the quarter before

Positions

31

13 new, 22 sold out

Top 10

75.8%

of the value

Est. gain

−$158.8M

on stocks held all quarter

Est. return

−12.8%

on those stocks since Q3 2018

Filed

Feb 14, 2019

On SEC EDGAR ↗

Positions as of Dec 31, 2018, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.

Microsoft27%Amazon8.6%Salesforce8.5%TeslaPUT5.8%
Abbott Labs5.4%
Workday4.9%
Coupa Software Inc4.1%
Adobe3.9%
Ishares Tr3.8%
Gilead Sciences Inc3.7%
Intuitive Surgical3.1%
7 others2.4%
Illumina Inc2.4%
PayPal2.0%
Medtronic Plc2.0%
Ishares Tr2.0%
Delta Air Lines Inc Del1.8%
Alibaba1.4%
Ac Immune Sa1.4%
MercadoLibre1.3%Netflix1.0%
American Airls Group Inc1.0%
0.9%
0.8%
0.8%

Largest buys

Since Q3 2018, sized at quarter-end prices.

  1. Microsoft~$111.0MAdded, 19.2% → 27.2% of the portfolio+1,093,171 shares
  2. TeslaPUT~$99.8MNew, 0.0% → 5.8% of the portfolio+299,800 underlying
  3. Ishares Tr~$65.6MNew, 0.0% → 3.8% of the portfolio+1,679,700 shares
  4. Coupa Software Inc~$62.3MAdded, 0.5% → 4.1% of the portfolio+990,900 shares
  5. Intuitive Surgical~$52.8MNew, 0.0% → 3.1% of the portfolio+110,300 shares
  6. Illumina Inc~$41.8MNew, 0.0% → 2.4% of the portfolio+139,500 shares
  7. Abbott Labs~$40.8MAdded, 2.6% → 5.4% of the portfolio+563,600 shares
  8. Delta Air Lines Inc Del~$31.3MNew, 0.0% → 1.8% of the portfolio+626,600 shares
  9. MercadoLibre~$21.7MNew, 0.0% → 1.3% of the portfolio+74,016 shares
  10. American Airls Group Inc~$16.9MNew, 0.0% → 1.0% of the portfolio+524,900 shares

Largest sells

Since Q3 2018, sized at quarter-end prices.

  1. Alphabet~$186.2MCut, 10.9% → 0.7% of the portfolio−178,201 shares
  2. Ishares Tr~$65.8MCut, 6.0% → 2.0% of the portfolio−682,600 shares
  3. Salesforce~$65.8MCut, 11.7% → 8.5% of the portfolio−480,115 shares
  4. Citigroup Inc~$47.9MSold out, 2.3% → 0.0% of the portfolio−667,100 shares
  5. Select Sector SPDR Tr~$39.6MSold out, 1.9% → 0.0% of the portfolio−522,900 shares
  6. Vaneck Vectors ETF Tr~$39.4MSold out, 1.9% → 0.0% of the portfolio−1,565,100 shares
  7. Amazon~$29.8MCut, 11.3% → 8.6% of the portfolio−19,867 shares
  8. Gilead Sciences Inc~$27.6MCut, 5.4% → 3.7% of the portfolio−441,555 shares
  9. PayPal~$26.8MCut, 3.0% → 2.0% of the portfolio−318,965 shares
  10. Twenty First Centy Fox Inc~$25.8MSold out, 1.2% → 0.0% of the portfolio−557,800 shares

Holdings

As of Dec 31, 2018; changes in shares since Sep 30, 2018.

Positions, sorted by share of the portfolio
HoldingValue
MicrosoftCOM · shares +31% · price −11.2%27.2%$469.1M−$45.1M
AmazonCOM · shares −17% · price −25.0%8.6%$147.8M−$49.3M
SalesforceCOM · shares −31% · price −13.9%8.5%$146.9M−$23.7M
TeslaPUTCOM · shares New5.8%$99.8M—
Abbott LabsCOM · shares +77% · price −1.4%5.4%$93.7M−$754,196
WorkdayCL A · shares +17% · price +9.4%4.9%$83.9M+$6.1M
Coupa Software IncCOM · shares +707% · price −20.5%4.1%$71.1M−$2.3M
AdobeCOM · shares +13% · price −16.2%3.9%$68.1M−$11.7M
Ishares TrMSCI EMG MKT ETF · shares New3.8%$65.6M—
Gilead Sciences IncCOM · shares −30% · price −19.0%3.7%$64.0M−$15.0M
Intuitive SurgicalCOM NEW · shares New3.1%$52.8M—
Illumina IncCOM · shares New2.4%$41.8M—
PayPalCOM · shares −44% · price −4.3%2.0%$34.4M−$1.5M
Medtronic PlcSHS · shares 0% · price −7.5%2.0%$33.9M−$2.8M
Ishares TrNASDAQ BIOTECH · shares −66% · price −20.9%2.0%$33.8M−$8.9M
Delta Air Lines Inc DelCOM NEW · shares New1.8%$31.3M—
AlibabaSPONSORED ADS · shares +123% · price −16.8%1.4%$23.9M−$2.2M
Ac Immune SaSHS · shares 0% · price +18.1%1.4%$23.5M+$3.6M
MercadoLibreCOM · shares New1.3%$21.7M—
NetflixCOM · shares +1,169% · price −28.4%1.0%$17.7M−$553,187
American Airls Group IncCOM · shares New0.98%$16.9M—
Agilent Technologies IncCOM · shares New0.86%$14.9M—
ServiceNowCOM · shares −58% · price −9.0%0.85%$14.6M−$1.4M
Hologic IncCOM · shares New0.80%$13.8M—
AlphabetCAP STK CL A · shares −94% · price −13.4%0.68%$11.8M−$1.8M
Total 31 positions100%$1.73B−$158.8M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2018 to Q4 2018: 18 stocks held throughout, down $158.8M (−12.8%).

  1. Workday+$6.1M+9%
  2. Ac Immune Sa+$3.6M+18%
  3. Adobe−$11.7M−16%
  4. Gilead Sciences Inc−$15.0M−19%
  5. Salesforce−$23.7M−14%
  6. Microsoft−$45.1M−11%
  7. Amazon−$49.3M−25%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free